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Abstract
We investigated whether transforming growth factor-L (TGF-L) stimulates the induction of heat shock protein (HSP) 27
and HSP70 in osteoblast-like MC3T3-E1 cells and the mechanism underlying the induction. TGF-L increased the level of
HSP27 but had no effect on the HSP70 level. TGF-L stimulated the accumulation of HSP27 dose-dependently, and induced
an increase in the level of mRNA for HSP27. TGF-L induced the phosphorylation of p44/p42 mitogen-activated protein
(MAP) kinase and p38 MAP kinase. The HSP27 accumulation induced by TGF-L was significantly suppressed by PD98059,
an inhibitor of the upstream kinase of p44/p42 MAP kinase, or SB203580, an inhibitor of p38 MAP kinase. PD98059 and
SB203580 suppressed the TGF-L-stimulated increase in the level of mRNA for HSP27. Retinoic acid, a vitamin A (retinol)
metabolite, which alone had little effect on the HSP27 level, markedly enhanced the HSP27 accumulation stimulated by
TGF-L. Retinoic acid enhanced the TGF-L-induced increase of mRNA for HSP27. The amplification of TGF-L-stimulated
HSP27 accumulation by retinoic acid was reduced by PD98059 or SB203580. Retinoic acid failed to affect the TGF-L-
induced phosphorylation of p44/p42 MAP kinase or p38 MAP kinase. These results strongly suggest that p44/p42 MAP
kinase and p38 MAP kinase take part in the pathways of the TGF-L-stimulated HSP27 induction in osteoblasts, and that
retinoic acid upregulates the TGF-L-stimulated HSP27 induction at a point downstream from p44/p42 MAP kinase and p38
MAP kinase. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Transforming growth factor-L (TGF-L) is a multi-
functional cytokine that regulates cell growth, di¡er-
entiation and extracellular matrix production [1].
Bone metabolism is maintained by two types of func-
tional bone cells, osteoblasts and osteoclasts, which
are responsible for bone formation and bone resorp-
tion, respectively [2]. In bone tissue, TGF-L is pro-
duced by osteoblasts, and TGF-L is abundantly
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stored as a latent form in bone matrix tissue [3].
TGF-L is released by osteoclasts as an active TGF-
L and the active TGF-L could act to both stimulate
new bone formation and limit the extent of further
bone resorption [3]. TGF-L stimulates the recruit-
ment and proliferation of osteoblasts responsible
for new bone formation [3]. In osteoblasts, it has
been reported that TGF-L regulates K1(I) collagen
gene expression, and causes the induction of osteo-
protegerin/osteoclastogenesis inhibitory factor
mRNA, and induces vascular endothelial growth fac-
tor expression [4^6]. Taken together, TGF-L is well
recognized to be an important cytokine in bone me-
tabolism.
The intracellular signaling of TGF-L is initiated
following ligand binding to the TGF-L type II recep-
tor, which phosphorylates TGF-L type I receptor
resulting in the activation of type I receptor [7,8].
It is generally recognized that the activated TGF-L
type I receptor phosphorylates Smad 2 and Smad 3.
Phosphorylated Smad 2 and Smad 3 form a complex
with Smad 4, and these complexes translocate into
the nucleus where they can bind to DNA in the pro-
moters of TGF-L target genes or interact with DNA-
binding proteins to form a transcriptional activator
complex [9^12]. In addition to this signaling path-
way, other signaling pathways such as the mitogen-
activated protein (MAP) kinase superfamily have re-
cently been shown to mediate TGF-L signaling.
Three MAP kinases, p44/p42 MAP kinase, p38
MAP kinase, and c-Jun N-terminal kinase (JNK)
are known as central elements used by mammalian
cells to transduce the diverse messages [13]. TGF-L-
activated kinase (TAK1), a member of the MAP ki-
nase kinase kinase family, has been identi¢ed as up-
stream kinase of MAP kinase [14]. The kinase activ-
ity of TAK1 is stimulated by TGF-L in osteoblast-
like MC3T3-E1 cells [14]. TGF-L reportedly activates
the p44/p42 MAP kinase pathway in primary cul-
tured arterial endothelial cells [15]. Additionally, it
has been shown that TGF-L activates the p38
MAP kinase pathway and p38 MAP kinase is in-
volved in the TGF-L-induced transcriptional activa-
tion by regulating the Smad-mediated pathway in
C2C12 pluripotent mesenchymal precursor cells
[16]. However, the exact roles of the MAP kinase
superfamily in the TGF-L signaling system in osteo-
blasts are still poorly understood.
Cells produce heat shock proteins (HSPs), when
exposed to biological stress such as heat [17]. HSPs
are classi¢ed into high molecular weight HSPs and
low molecular weight HSPs according to apparent
molecular sizes. High molecular weight HSPs such
as HSP110, HSP90 and HSP70 are well recognized
as acting as molecular chaperones in protein folding,
oligomerization and translocation [18]. Though the
functions of low molecular weight HSPs are less
known than those of high molecular weight HSPs,
it is recognized that they also may act as molecular
chaperones like high molecular weight HSPs [17]. In
osteoblasts, the expression of HSP27 is induced by
heat, and the heat-induced HSP27 expression is re-
portedly facilitated by estrogen [19,20]. In addition,
the downregulation of proliferation has been shown
to be accompanied by a transient increase of the
expression of HSP27 mRNA [19,20]. However, the
exact mechanism behind the HSP27 induction in os-
teoblasts and its roles have not yet been precisely
clari¢ed. As for TGF-L e¡ects on HSPs in osteo-
blasts, it has been reported that TGF-L induces
HSP27 phosphorylation in osteoblast-like MC3T3-
E1 cells [21], and TGF-L causes an increase in the
steady state level of HSP47 mRNA in these cells [22].
Steroid hormones such as thyroid hormone, vita-
min D3, estrogen, and retinoic acid consist of the
steroid hormone receptor superfamily of ligand-in-
ducible transcription factors [23]. It is well known
that the e¡ects of steroid hormones are exerted via
binding to speci¢c intracellular receptors and subse-
quently activating the expression of gene network
[23]. Among them, retinoic acid, a vitamin A (reti-
nol) metabolite, has marked e¡ects on proliferation
and di¡erentiation of a variety of cells [23]. The re-
ceptors for retinoic acid have been demonstrated to
exist in osteoblast-like MC3T3-E1 cells [24]. As for
bone metabolism, retinoic acid is recognized to act as
a bone resorptive agent [25]. Accumulating evidence
indicates that steroid hormones modulate intracellu-
lar signaling by other agonists [24^26]. Recently, it
has been shown that the ligand-dependent interac-
tion between Smad 3 and retinoid X receptor/vitamin
D receptor heterocomplex is observed and the coop-
erative actions of TGF-L and vitamin D signaling
pathways are mediated by Smad 3 [28]. Thus, we
thought it possible that retinoic acid might modulate
TGF-L signaling in osteoblast-like MC3T3-E1 cells.
BBAMCR 14832 21-2-02
D. Hatakeyama et al. / Biochimica et Biophysica Acta 1589 (2002) 15^3016
In the present study, we investigated the e¡ects of
TGF-L on the induction of HSP27 and HSP70 in
MC3T3-E1 cells and the potential cross-talk between
TGF-L signaling and retinoic acid signaling. We here
report that both p44/p42 MAP kinase and p38 MAP
kinase take part in TGF-L-stimulated HSP27 induc-
tion in these cells and that retinoic acid ampli¢es the
HSP27 induction by TGF-L.
2. Materials and methods
2.1. Materials
TGF-L and epidermal growth factor (EGF) were
obtained from RpD Systems (Minneapolis, MN,
USA). Anisomycin was obtained from Calbiochem-
Novabiochem (La Jolla, CA, USA). Inducible
HSP70 antibodies were purchased from Santa Cruz
(Santa Cruz, CA, USA). PD98059, SB203580 and
PD169316 were obtained from Calbiochem-Novabio-
chem. All trans retinoic acid was purchased from
Sigma (St. Louis, MO, USA). Phospho-speci¢c p44/
p42 MAP kinase antibodies (rabbit polyclonal IgG,
a⁄nity puri¢ed), and p44/p42 MAP kinase antibod-
ies (rabbit polyclonal IgG, a⁄nity puri¢ed), phos-
pho-speci¢c p38 MAP kinase antibodies (rabbit poly-
clonal IgG, a⁄nity puri¢ed), p38 MAP kinase
antibodies (rabbit polyclonal IgG, a⁄nity puri¢ed),
phospho-speci¢c JNK antibodies (rabbit polyclonal
IgG, a⁄nity puri¢ed) and phospho-speci¢c Smad 2
antibodies were purchased from New England Bio-
Labs (Beverly, MA, USA). An ECL Western blot-
ting detection system was obtained from Amersham
Japan (Tokyo, Japan). Other materials and chemicals
were obtained from commercial sources. PD98059,
SB203580 and PD169316 were dissolved in dimethyl
sulfoxide. The maximum concentration of dimethyl
sulfoxide was 0.1% (v/v), which did not a¡ect West-
ern blot analysis, immunoassay of HSP27 or North-
ern blot analysis of HSP27.
2.2. Cell culture
Cloned osteoblast-like MC3T3-E1 cells derived
from newborn mouse calvaria [29] were maintained
as previously described [30]. In brief, the cells were
cultured in K-minimum essential medium (K-MEM)
containing 10% (v/v) fetal calf serum (FCS) at 37‡C
in a humidi¢ed atmosphere of 5% CO2/95% air. The
cells were seeded into 35 mm diameter dishes or 90
mm diameter dishes in K-MEM containing 10%
FCS. After 5 days, the medium was exchanged for
2 ml of K-MEM containing 0.3% FCS. The cells were
used for experiments after 48 h. When indicated, the
cells were pretreated with PD98059, SB203580 or
PD169316 for 60 min. The pretreatment of retinoic
acid was performed for 8 h.
2.3. Western blot analysis of HSP27, HSP70, p44/
p42 MAP kinase and p38 MAP kinase
The cultured cells were stimulated by TGF-L in K-
MEM for the indicated periods. For heat treatment,
dishes containing cells were £oated in a water bath at
43‡C for 30 min and then returned to the incubator
for 12 h. When indicated, the cultured cells were
stimulated by EGF (30 ng/ml) for 10 min or aniso-
mycin (100 nM) for 20 min, respectively. The cells
were washed twice with phosphate-bu¡ered saline
(PBS) and then lysed, homogenized and sonicated
in a lysis bu¡er containing 62.5 mM Tris^HCl, pH
6.8, 2% (w/v) sodium dodecyl sulfate (SDS), 50 mM
dithiothreitol and 10% glycerol. The cytosolic frac-
tion was collected as the supernatant after centrifu-
gation at 125 000Ug for 10 min at 4‡C. SDS^poly-
acrylamide gel electrophoresis (PAGE) was
performed by the method of Laemmli [31] in 10%
polyacrylamide gel. Western blotting analysis was
performed as described previously [32] using HSP27
antibodies, HSP70 antibodies, phospho-speci¢c p44/
p42 MAP kinase antibodies, p44/p42 MAP kinase
antibodies, phospho-speci¢c p38 MAP kinase anti-
bodies, p38 MAP kinase antibodies, phospho-JNK
antibodies or phospho-speci¢c Smad 2 antibodies,
with peroxidase-labeled antibodies raised in goat
against rabbit IgG being used as second antibodies.
Peroxidase activity on the nitrocellulose sheet was
visualized on X-ray ¢lm by means of the ECL West-
ern blotting detection system.
2.4. Immunoassay of HSP27
The concentration of HSP27 in soluble extracts of
cells was determined by sandwich-type enzyme im-
munoassays, as described previously [33]. The cul-
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tured cells were stimulated by TGF-L in K-MEM for
the indicated periods. The cells were then washed
twice with 1 ml of PBS, and frozen at 380‡C for a
few days before analysis. The frozen cells on each
dish were collected and suspended in 0.3 ml of
PBS, and each suspension was sonicated and centri-
fuged at 125 000Ug for 20 min at 4‡C. The super-
natant was used for the speci¢c immunoassay of
HSP27. In brief, we used an enzyme immunoassay
system that employs polystyrene balls (3.2 mm in
diameter, Immuno Chemicals, Okayama, Japan) car-
rying immobilized F(abP)2 fragments of antibody and
the same FabP fragments labeled with L-D-galactosi-
dase from Escherichia coli. A polystyrene ball carry-
ing antibodies was incubated either with the puri¢ed
standard for HSP27 or with an aliquot of the sam-
ples. This incubation was carried out at 30‡C for 5 h
in a ¢nal volume of 0.5 ml of 10 mM sodium phos-
phate bu¡er, pH 7.0, containing 0.3 M NaCl, 0.5%
(w/v) hydrolyzed gelatin, 0.1% (w/v) bovine serum
albumin (BSA), 1 mM MgCl2 and 0.1% (w/v)
NaN3. After washing, each ball was incubated at
4‡C overnight with 1.5 milliunits of galactosidase-la-
beled antibodies in a volume of 0.2 ml with 10 mM
sodium phosphate bu¡er, pH 7.0, containing 0.1 M
NaCl, 1 mM MgCl2, 0.1% BSA and 0.1% NaN3. The
galactosidase activity bound to the ball was assayed
using a £uorogenic substrate, 4-methylumbelliferyl
L-D-galactoside.
2.5. Isolation of RNA and Northern blot analysis
of HSP27
The cultured cells were stimulated by TGF-L in
K-MEM for the indicated periods. Total RNA was
isolated using a QuickPrep Total RNA Extraction
kit (Pharmacia Biotech, Tokyo, Japan). Then, 20
Wg of total RNA were subjected to electrophoresis
on a 0.9% agarose^2.2 M formaldehyde gel, and
blotted onto a nitrocellulose membrane. For North-
ern blot analysis, the membrane was allowed to
hybridize with a cDNA probe that had been la-
beled using a Multiprime DNA labeling system
(Amersham, Buckinghamshire, UK), as described
previously [32]. A BamHI-HindIII fragment of
cDNA for mouse HSP27 [20] was kindly provided
by Dr. L.F. Cooper of the University of North
Carolina.
2.6. Sucrose density gradient centrifugation
The cultured cells were exposed to heat (43‡C, 30
min). After 12 h, the cells were stimulated by TGF-L.
Extract of the cells was layered over a 3.5 ml linear
gradient of sucrose (10^40%) in 50 mM Tris^HCl,
pH 7.0, that contained 5 mM EDTA and was cen-
trifuged at 130 000Ug for 16 h at 4‡C in a swinging
bucket rotor (RPS56T, Hitachi). After centrifuga-
tion, each sample was fractionated into 15 test tubes,
each of which contained 0.25 ml of 0.1% BSA.
2.7. Other methods
Protein concentrations in soluble extracts were de-
termined using a protein assay kit (Bio-Rad, Her-
cules, CA, USA), with BSA as the standard protein.
Rat HSP27, which was used as the standard for the
immunoassay, was puri¢ed from skeletal muscle [33].
The densitometric analysis was performed using Mo-
lecular Analyst/Macintosh (Bio-Rad).
2.8. Statistical analysis
Each experiment was repeated three times with
similar results. The data were analyzed by ANOVA
followed by the Bonferroni method for multiple com-
parisons between pairs, and a P6 0.05 was consid-
Fig. 1. E¡ects of TGF-L on HSP27 and HSP70 induction in
MC3T3-E1 cells. The cultured cells were stimulated by 3 ng/ml
TGF-L for the indicated periods. The extracts of cells were sub-
jected to SDS^PAGE against HSP27 antibodies or HSP70 anti-
bodies. Lower blots show the positive controls for the induction
of HSP27 and HSP70 by heat (43‡C, 30 min).
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ered signi¢cant. All data are presented as the
mean þ S.D. of three di¡erent sample sets.
3. Results
3.1. E¡ects of TGF-L on HSP27 and
HSP70 induction in MC3T3-E1 cells
In unstimulated MC3T3-E1 cells, the level of
HSP27 was quite low. On the other hand, HSP70
clearly exists. TGF-L (3 ng/ml) time-dependently in-
creased the level of HSP27 and the maximum level of
HSP27 was observed at 12 h after stimulation. How-
ever, TGF-L did not a¡ect the level of HSP70 in the
same sample (Fig. 1). We showed the induction of
HSP27 or HSP70 by heat shock as a loading positive
control. HSP27 and HSP70 were truly induced by
heat in osteoblast-like MC3T3-E1 cells.
3.2. E¡ect of TGF-L on HSP27 accumulation in
MC3T3-E1 cells
To clarify the e¡ect of TGF-L on HSP27 induction
in MC3T3-E1 cells, we determined the level of
HSP27 by a speci¢c immunoassay. TGF-L (3 ng/
ml) signi¢cantly stimulated the accumulation of
HSP27 time-dependently up to 48 h (Fig. 2A). The
maximum e¡ect of TGF-L on HSP27 accumulation
was observed at 12 h after stimulation and the level
of HSP27 decreased thereafter. The stimulative e¡ect
of TGF-L on HSP27 accumulation was dose-depen-
dent in the range between 0.1 and 10 ng/ml (Fig. 2B).
The maximal e¡ect of TGF-L on HSP27 accumula-
tion was observed at 10 ng/ml.
Fig. 2. E¡ect of TGF-L on HSP27 accumulation in MC3T3-E1 cells. (A) The cultured cells were stimulated by 3 ng/ml TGF-L (b) or
vehicle (a) for the indicated periods. (B) The cultured cells were stimulated by various doses of TGF-L for 12 h. Each value repre-
sents the mean þ S.D. of three di¡erent sample sets. Similar results were obtained with two additional and di¡erent cell preparations.
*P6 0.05, compared to the control value.
Fig. 3. Northern blot analysis of the mRNA for HSP27 in re-
sponse to TGF-L in MC3T3-E1 cells. The cultured cells were
stimulated by 3 ng/ml TGF-L for the indicated periods. The
cells were then harvested and total RNA was isolated. Twenty
micrograms of RNA from each sample were subjected to elec-
trophoresis and blotted onto a nitrocellulose membrane. The
membrane was then allowed to hybridize with the cDNA probe
for HSP27 or L-actin. Lane 1, control cells. Bands of L-actin
are shown for reference.
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3.3. Northern blot analysis of the mRNA for HSP27
in response to TGF-L in MC3T3-E1 cells
The expression level of the mRNA for HSP27 was
markedly increased by TGF-L, which had little e¡ect
on the level of L-actin mRNA (Fig. 3). The maximal
e¡ect of TGF-L on the mRNA level for HSP27 was
observed at 4 h after stimulation.
3.4. E¡ects of TGF-L on the phosphorylation of
p44/p42 MAP kinase and p38 MAP kinase in
MC3T3-E1 cells
To investigate whether or not TGF-L activates
p44/p42 MAP kinase and p38 MAP kinase in osteo-
blast-like MC3T3-E1 cells, we next examined the ef-
fect of TGF-L on the phosphorylation of p44/p42
MAP kinase and p38 MAP kinase. TGF-L markedly
induced the phosphorylation of p44/p42 MAP kinase
and p38 MAP kinase in a time-dependent manner
(Fig. 4). We showed the phosphorylation of p44/
p42 MAP kinase by EGF and the phosphorylation
of p38 MAP kinase by anisomycin, a direct activator
of p38 MAP kinase, as loading positive controls.
3.5. E¡ects of PD98059, SB203580 and PD169316 on
TGF-L-induced HSP27 accumulation in
MC3T3-E1 cells
In order to investigate whether or not p44/p42
MAP kinase is involved in the TGF-L-stimulated
HSP27 induction in MC3T3-E1 cells, we examined
the e¡ect of PD98059, a speci¢c inhibitor of the up-
stream kinase that activates p44/p42 MAP kinase
[34], on the HSP27 accumulation stimulated by
TGF-L. PD98059, which alone had little e¡ect on
the basal level of HSP27, signi¢cantly reduced
HSP27 accumulation by TGF-L (Fig. 5, left). The
inhibitory e¡ect of PD98059 on the TGF-L-induced
HSP27 accumulation was dose-dependent in the
range between 0.1 and 30 WM. The maximal e¡ect
of PD98059 was observed at 30 WM, a dose that
caused about 50% reduction in the e¡ect of TGF-L
(Fig. 5, left). We next investigated the involvement of
p38 MAP kinase in the TGF-L-stimulated HSP27
induction in MC3T3-E1 cells. SB203580, an inhibitor
of p38 MAP kinase [35], which by itself did not a¡ect
the basal level of HSP27, markedly suppressed the
HSP27 accumulation induced by TGF-L in a dose-
dependent manner in the range between 0.1 and 30
WM. The maximal e¡ect of SB203580 was observed
at 30 WM, a dose that caused about 80% reduction in
the e¡ect of TGF-L (Fig. 5B). Moreover, we exam-
ined the e¡ect of PD169316, another inhibitor of p38
MAP kinase [36], on the accumulation of HSP27
induced by TGF-L. PD169316 (10 WM), which alone
had little e¡ect on the level of HSP27, markedly re-
Fig. 4. E¡ects of TGF-L on the phosphorylation of p44/p42
MAP kinase and p38 MAP kinase in MC3T3-E1 cells. The cul-
tured cells were stimulated by 3 ng/ml TGF-L for the indicated
periods. The extracts of cells were subjected to SDS^PAGE
against phospho-speci¢c p44/p42 MAP kinase antibodies, p44/
p42 MAP kinase antibodies, phospho-speci¢c p38 MAP kinase
antibodies or p38 MAP kinase antibodies. Each lower blot
shows the positive control for the EGF-induced phosphoryla-
tion of p44/p42 MAP kinase or the anisomycin-induced phos-
phorylation of p38 MAP kinase.
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duced the HSP27 accumulation (control, 13.7 þ 1.3
ng/mg protein; TGF-L alone, 245.7 þ 24.6 ng/mg
protein; 10 WM PD169316 alone, 10.7 þ 1.5 ng/mg
protein; TGF-L plus 10 WM PD169316, 129.2 þ 6.0*
ng/mg protein, as measured after 12 h stimulation,
*P6 0.05). In this study, we found that the viability
of the cells treated with 30 WM PD98059, 30 WM
SB203580 or 10 WM PD169316 for 13 h was more
than 90%, as assessed by trypan blue staining.
3.6. E¡ects of PD98059 and SB203580 on the
mRNA level for HSP27 in response to TGF-L
in MC3T3-E1 cells
We further examined the e¡ects of PD98059 and
SB203580 on the TGF-L-induced increase in the level
of mRNA for HSP27 in MC3T3-E1 cells. Both
PD98059 and SB203580 signi¢cantly suppressed the
TGF-L-increased level of mRNA for HSP27 (Fig. 6).
Fig. 5. E¡ects of PD98059 and SB203580 on TGF-L-induced HSP27 accumulation in MC3T3-E1 cells. The cultured cells were pre-
treated with various doses of PD98059 (left) or SB203580 (B) for 60 min, and then stimulated by 3 ng/ml TGF-L (b) or vehicle (a)
for 12 h. Each value represents the mean þ S.D. of three di¡erent sample sets. Similar results were obtained with two additional and
di¡erent cell preparations. *P6 0.05, compared to the value of TGF-L alone.
C
Fig. 6. E¡ects of PD98059 and SB203580 on the mRNA levels
for HSP27 in response to TGF-L in MC3T3-E1 cells. The cul-
tured cells were pretreated with 30 WM PD98059, 30 WM
SB203580 or vehicle for 60 min, and then stimulated by 3 ng/
ml TGF-L or vehicle for 4 h. The cells were harvested and total
RNA was isolated. Twenty micrograms of RNA from each
sample were subjected to electrophoresis and blotted onto a ni-
trocellulose membrane. The membrane was then allowed to hy-
bridize with the cDNA probe for HSP27 or L-actin. Bands of
L-actin are shown for reference. The histogram shows quantita-
tive representations of TGF-L-induced HSP27 mRNA levels ob-
tained from laser densitometric analysis after normalization to
the levels of L-actin mRNA of three independent experiments.
Each value represents the mean þ S.D. of three di¡erent sample
sets. Similar results were obtained with two additional and dif-
ferent cell preparations. *P6 0.05, compared to the value of
TGF-L alone.
BBAMCR 14832 21-2-02
D. Hatakeyama et al. / Biochimica et Biophysica Acta 1589 (2002) 15^30 21
BBAMCR 14832 21-2-02
D. Hatakeyama et al. / Biochimica et Biophysica Acta 1589 (2002) 15^3022
According to densitometric analysis after normaliza-
tion to the level of L-actin mRNA, PD98059 caused
33% reduction and SB203580 caused 39% reduction
in the TGF-L-increased level of HSP27 mRNA.
3.7. E¡ects of PD98059 and SB203580 on
TGF-L-induced phosphorylation of MAP kinases
in MC3T3-E1 cells
We showed that PD98059 actually inhibited the
TGF-L-induced phosphorylation of p44/p42 MAP
kinase (Fig. 7A). In addition, SB203580 suppressed
the phosphorylation of p38 MAP kinase stimulated
by TGF-L (Fig. 7B). However, PD98059 did not af-
fect the phosphorylation of p38 MAP kinase induced
by TGF-L (Fig. 7C) and SB203580 had little e¡ect
on the TGF-L-stimulated p44/p42 MAP kinase phos-
phorylation (Fig. 7D). In addition, we examined the
e¡ect of PD98059 and SB203580 on the TGF-L-in-
duced phosphorylation of JNK. PD98059 and
SB203580 did not a¡ect the TGF-L-induced phos-
phorylation of JNK (Fig. 7E,F). Furthermore, both
PD98059 and SB203580 had little e¡ect on the level
of HSP70 (Fig. 7E,F). We showed the phosphoryla-
tion of p44/p42 MAP kinase by EGF and the phos-
phorylation of p38 MAP kinase by anisomycin as
loading positive controls.
Fig. 7. E¡ects of PD98059 on the TGF-L-induced phosphorylation of p44/p42 MAP kinase and of SB203580 on the TGF-L-induced
phosphorylation of p38 MAP kinase in MC3T3-E1 cells. The cultured cells were pretreated with 30 WM PD98059 (A,C,E) or 30 WM
SB203580 (B,D,F) for 60 min, and then stimulated by 3 ng/ml TGF-L or vehicle for 120 min or 12 h (HSP70). Extracts of cells were
subjected to SDS^PAGE against phospho-speci¢c p44/p42 MAP kinase antibodies or p44/p42 MAP kinase antibodies (A,D), against
phospho-speci¢c p38 MAP kinase antibodies or p38 MAP kinase antibodies (B,C), against phospho-speci¢c JNK antibodies, HSP70
antibodies (E,F), or phospho-speci¢c Smad 2 antibodies (G). Each lower blot shows the positive control for the EGF-induced phos-
phorylation of p44/p42 MAP kinase or the anisomycin-induced phosphorylation of p38 MAP kinase (A^D).
6
Fig. 8. E¡ect of retinoic acid on TGF-L-induced HSP27 accu-
mulation in MC3T3-E1 cells. The cultured cells were pretreated
with various doses of retinoic acid for 8 h, and then stimulated
by 3 ng/ml TGF-L (b) or vehicle (a) for 12 h. Each value rep-
resents the mean þ S.D. of three di¡erent sample sets. Similar
results were obtained with two additional and di¡erent cell
preparations. *P6 0.05, compared to the value of TGF-L
alone.
Fig. 9. E¡ect of retinoic acid on the level of mRNA for HSP27
by TGF-L in MC3T3-E1 cells. The cultured cells were pre-
treated with 0.1 WM retinoic acid or vehicle for 8 h, and then
stimulated by 3 ng/ml TGF-L for 2 h. The cells were harvested
and total RNA was isolated. Twenty micrograms of RNA from
each sample were subjected to electrophoresis and blotted onto
a nitrocellulose membrane. The membrane was then allowed to
hybridize with the cDNA probe for HSP27 or L-actin. Bands
of L-actin are shown for reference. The histogram shows quan-
titative representations of TGF-L-induced HSP27 mRNA level
obtained from laser densitometric analysis after normalization
to the levels of L-actin mRNA of three independent experi-
ments. Each value represents the mean þ S.D. of three di¡erent
sample sets. Similar results were obtained with two additional
and di¡erent cell preparations. *P6 0.05, compared to the val-
ue of TGF-L alone.
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It has been reported that SB203580 can also inhib-
it kinase activation of TGF-L type I receptor [37].
Thus, we next examined the e¡ect of SB203580 on
the phosphorylation of Smad 2 induced by TGF-L.
SB203580 (30 WM) failed to a¡ect the phosphoryla-
tion of Smad 2 stimulated by TGF-L (Fig. 7G).
3.8. E¡ect of retinoic acid on TGF-L-induced
HSP27 accumulation in MC3T3-E1 cells
In order to clarify the interaction between the ret-
inoic acid signaling and the TGF-L signaling system
in MC3T3-E1 cells, we examined the e¡ect of retino-
ic acid on the TGF-L-stimulated HSP27 accumula-
tion. Retinoic acid, which alone had little e¡ect on
the basal level of HSP27, signi¢cantly enhanced the
TGF-L-induced HSP27 accumulation in the range
between 0.1 nM and 0.1 WM. The maximal e¡ect of
retinoic acid on the HSP27 accumulation by TGF-L
was observed at 0.1 WM, a dose that caused about
200% ampli¢cation in the e¡ect of TGF-L alone
(Fig. 8).
3.9. E¡ect of retinoic acid on the mRNA level for
HSP27 in response to TGF-L in MC3T3-E1 cells
We next examined the e¡ect of retinoic acid on the
TGF-L-induced increase in the level of mRNA for
HSP27 in MC3T3-E1 cells. Retinoic acid signi¢-
cantly ampli¢ed the TGF-L-increased level of
mRNA for HSP27 as well as the HSP27 accumula-
tion by a speci¢c immunoassay (Fig. 9A). According
to densitometric analysis after normalization to the
level of L-actin mRNA, retinoic acid caused about
40% ampli¢cation in the TGF-L-increased level of
HSP27 mRNA (Fig. 9B).
3.10. E¡ects of PD98059 and SB203580 on
retinoic acid ampli¢cation of TGF-L-induced
HSP27 accumulation in MC3T3-E1 cells
In addition, we examined the e¡ects of PD98059
and SB203580 on the enhancement of TGF-L-in-
duced HSP27 accumulation by retinoic acid.
PD98059 and SB203580 markedly suppressed the ret-
inoic acid ampli¢cation of TGF-L-induced HSP27
accumulation as well as the HSP27 accumulation
by TGF-L alone (Fig. 10).
3.11. E¡ects of retinoic acid on the TGF-L-induced
phosphorylation of p44/p42 MAP kinase and
p38 MAP kinase in MC3T3-E1 cells
We next investigated whether or not retinoic acid
a¡ects the activation of p44/p42 MAP kinase and
p38 MAP kinase stimulated by TGF-L. Retinoic
acid did neither a¡ect the TGF-L-induced phosphor-
ylation of p44/p42 MAP kinase nor that of p38 MAP
Fig. 10. E¡ects of PD98059 and SB203580 on the enhancement of TGF-L-induced HSP27 accumulation by retinoic acid in MC3T3-
E1 cells. The cultured cells were pretreated with 0.1 WM retinoic acid or vehicle for 8 h, and then 30 WM PD98059 (A) or 30 WM
SB203580 (B) for 60 min, and stimulated by 3 ng/ml TGF-L (b) or vehicle (a) for 12 h. Each value represents the mean þ S.D. of
three di¡erent sample sets. Similar results were obtained with two additional and di¡erent cell preparations. *P6 0.05, compared to
the value of TGF-L alone. **P6 0.05, compared to the value of TGF-L with retinoic acid pretreatment.
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kinase (Fig. 11). We showed the phosphorylation of
p44/p42 MAP kinase by EGF and the phosphoryla-
tion of p38 MAP kinase by anisomycin as loading
positive controls.
3.12. E¡ect of TGF-L on the aggregated form of
heat-induced HSP27 in MC3T3-E1 cells
It is recognized that HSP27 exists in two forms, an
aggregated form and a dissociated form [38]. It has
been reported that the dissociation of HSP27 occurs
concomitantly with the phosphorylation of HSP27
[38]. Our speci¢c immunoassay of HSP27 detects
both an aggregated form and a dissociated form, as
previously described [38]. It has been reported that
TGF-L phosphorylates HSP27 in MC3T3-E1 cells,
analyzed by two-dimensional gel electrophoresis
[21]. We investigated the response to TGF-L of the
aggregated form of heat-induced HSP27. Extracts of
heat-exposed MC3T3-E1 cells contained both forms,
an aggregated form and a dissociated form. We
found that TGF-L increased the dissociated form
while decreasing the aggregated form (data not
shown).
4. Discussion
In the present study, we demonstrated that TGF-L
stimulated the level of HSP27 in osteoblast-like
MC3T3-E1 cells, as detected by Western blotting
analysis and speci¢c enzyme immunoassay. In addi-
tion, we showed that TGF-L increased the expression
level of mRNA for HSP27. Therefore, our ¢ndings
suggest that TGF-L, as a physiological agonist
for osteoblasts, stimulates the induction of HSP27,
a low molecular weight HSP, in osteoblast-like
MC3T3-E1 cells.
The MAP kinase superfamily is well recognized to
play important roles in intracellular signaling of a
variety of agonists [13]. In the present study, we
showed that TGF-L induced the phosphorylation of
p44/p42 MAP kinase in MC3T3-E1 cells. It is well
known that MAP kinase is activated by phosphory-
lation on both threonine and tyrosine residues by a
dual speci¢city kinase [39]. Thus, it is most likely that
TGF-L activates p44/p42 MAP kinase in these cells.
To clarify whether p44/p42 MAP kinase activation is
involved in the induction of HSP27 stimulated by
TGF-L in MC3T3-E1 cells, the e¡ect of PD98059
on HSP27 accumulation was next investigated.
PD98059 signi¢cantly reduced the HSP27 accumula-
tion by TGF-L. We found that the TGF-L-induced
phosphorylation of p44/p42 MAP kinase was truly
inhibited by PD98059. In addition, the TGF-L-in-
creased level of mRNA for HSP27 was markedly
reduced by PD98059. Therefore, our ¢ndings suggest
that p44/p42 MAP kinase activation is involved in
Fig. 11. E¡ects of retinoic acid on the TGF-L-stimulated phos-
phorylation of p44/p42 MAP kinase or p38 MAP kinase in
MC3T3-E1 cells. The cultured cells were pretreated with 0.1
WM retinoic acid or vehicle for 8 h, and then stimulated by
3 ng/ml TGF-L or vehicle for 120 min. (A) Extracts of cells
were subjected to SDS^PAGE against phospho-speci¢c p44/p42
MAP kinase antibodies or p44/p42 MAP kinase antibodies.
(B) Extracts of cells were subjected to SDS^PAGE against
phospho-speci¢c p38 MAP kinase antibodies or p38 MAP ki-
nase antibodies. Each lower blot shows the positive control for
the EGF-induced phosphorylation of p44/p42 MAP kinase or
the anisomycin-induced phosphorylation of p38 MAP kinase.
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the TGF-L-stimulated induction of HSP27 in osteo-
blast-like MC3T3-E1 cells.
p38 MAP kinase is another member of the MAP
kinase superfamily [13]. As for p38 MAP kinase in
osteoblasts, SKpF 86002, a cytokine-suppressant
anti-in£ammatory drug, has been shown to inhibit
cytokine-stimulated IL-6 synthesis through p38
MAP kinase in cultured neonatal mouse calvaria
and Saos-2 osteoblastic cells [40]. It has been re-
ported that the proliferation of osteoblasts in re-
sponse to EGF or hypoxia is associated with the
activation of not p38 MAP kinase but p44/p42
MAP kinase [41]. We previously reported that IL-
1K-induced IL-6 synthesis is mediated via activation
of both p44/p42 MAP kinase and p38 MAP kinase in
MC3T3-E1 cells [42]. Thus, we next investigated
whether or not TGF-L stimulates the activation of
p38 MAP kinase in MC3T3-E1 cells. The phosphor-
ylation of p38 MAP kinase was signi¢cantly stimu-
lated by TGF-L. Our ¢nding suggests that TGF-L
activates p38 MAP kinase in MC3T3-E1 cells. In
addition, SB203580 and PD169316 markedly sup-
pressed the HSP27 accumulation by TGF-L. We
found that SB203580 truly inhibited the TGF-L-in-
duced phosphorylation of p38 MAP kinase. There-
fore, it is probable that p38 MAP kinase is involved
in the TGF-L-stimulated HSP27 induction in
MC3T3-E1 cells. Additionally, SB203580 also re-
duced the TGF-L-increased level of mRNA for
HSP27. It has been reported that SB203580 can
also inhibit the kinase activity of TGF-L type I re-
ceptor [37]. It is generally recognized that the acti-
vated TGF-L type I receptor phosphorylates Smad 2
and Smad 3, which mediate the e¡ect of TGF-L [7,8].
Thus, we examined the e¡ect of SB203580 on the
phosphorylation of Smad 2 in MC3T3-E1 cells and
showed that SB203580 failed to a¡ect the phosphor-
ylation of Smad 2 induced by TGF-L. Based on our
¢ndings, it is most likely that p38 MAP kinase acti-
vation in addition to p44/p42 MAP kinase activation
is necessary for the TGF-L-stimulated HSP27 induc-
tion in osteoblast-like MC3T3-E1 cells. However,
each inhibitory e¡ect of PD98059 and SB203580 on
the TGF-L-increased HSP27 mRNA was partial.
Thus, these ¢ndings make us speculate that the com-
bination of p38 MAP kinase and p44/p42 MAP ki-
nase accounts for the entire induction of HSP27 in
response to TGF-L in MC3T3-E1 cells. In addition,
it is likely that other signaling pathways are involved
in TGF-L-stimulated HSP27 induction. In our pre-
vious studies [43,44], we have shown that not p44/
p42 MAP kinase but p38 MAP kinase is involved in
endothelin-1- and sphingosine 1-phosphate-stimu-
lated HSP27 induction in these cells. These di¡eren-
ces in the signaling of HSP27 induction may be due
to both agonists. Further investigations are necessary
to clarify the details.
It has been reported that p44/p42 MAP kinase
activated by EGF or hepatocyte growth factor inhib-
its the signaling of BMP-2, a member of the TGF-L
superfamily, via the phosphorylation of Smad 1 [45].
On the other hand, we here showed that the TGF-L-
stimulated p44/p42 MAP kinase activation acts as a
positive regulator in the TGF-L itself-induced HSP27
in MC3T3-E1 cells. Further investigations would be
required to clarify the relationship between the p44/
p42 MAP kinase signaling and the Smad signaling in
the TGF-L-stimulated HSP27 induction in osteo-
blast-like MC3T3-E1 cells since the role of Smad
signaling in the HSP27 induction by TGF-L is un-
clear.
The evidence of an implication between p38 MAP
kinase and HSP27 is accumulating in several cells,
showing that the activation of p38 MAP kinase leads
to the phosphorylation of HSP27 [18]. HSP27 exists
in two forms, an aggregated form and a dissociated
form. It is recognized that the dissociation of HSP27
occurs concomitantly with the phosphorylation of
HSP27, as described previously [38]. We showed
that HSP27 levels were low in unstimulated
MC3T3-E1 cells. Thus, we examined the possible ex-
istence of two forms of heat-induced HSP27 in these
cells. Extracts of heat-exposed cells contained both
forms, an aggregated form and a dissociated form.
We found that TGF-L increased the dissociated form
while decreasing the aggregated form. It has been
reported that TGF-L phosphorylates HSP27 in
MC3T3-E1 cells [21]. Taking these ¢ndings into ac-
count, it is most likely that TGF-L not only phos-
phorylates HSP27 but also stimulates its induction in
osteoblast-like MC3T3-E1 cells.
It is well recognized that high molecular weight
HSPs such as HSP70 act as molecular chaperones
[18]. It is speculated that low molecular weight
HSPs such as HSP27 may also act as chaperones
like high molecular weight HSPs [18]. It has been
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shown that heat stress induces both HSP70 and
HSP27 in osteoblasts [19]. In the present study,
TGF-L did not a¡ect the level of HSP70 in
MC3T3-E1 cells while increasing the level of
HSP27. The HSP70 family is composed of HSC70
and inducible HSP70. For the detection of 70 kDa
HSP, we used antibodies for inducible HSP70, which
are non-cross-reactive with HSC70. It is generally
recognized that inducible HSP70 usually is not ex-
pressed in cells under normal conditions. It has been
shown that HSC70 is induced by TGF-L in chicken
embryonic ¢broblasts [46]. On the contrary, we
found that inducible HSP70 was expressed in
MC3T3-E1 cells under normal conditions and the
level of HSP70 was not a¡ected by TGF-L. These
¢ndings lead us to speculate that HSP27 induced
by TGF-L may play an important role in osteoblast
functions following the stimulation by TGF-L.
TGF-L reportedly stimulates proliferation of os-
teoblast-like MC3T3-E1 cells [47]. In addition, it
has been shown that the expression of HSP27
mRNA increases with the downregulation of prolif-
eration in osteoblasts [19]. These ¢ndings made us
speculate that HSP27 expression may be necessary
for the inhibition of osteoblast proliferation. In ad-
dition, it has been reported that TGF-L increases the
synthesis of bone matrix via the activation of p44/
p42 MAP kinase and p38 MAP kinase in osteoblasts
[5,48]. We showed that TGF-L stimulated HSP27
induction via the activation of both p44/p42 MAP
kinase and p38 MAP kinase in MC3T3-E1 cells.
Based on these ¢ndings, it is possible that the induc-
tion of HSP27 by TGF-L may play an important role
in inducing osteoblastic bone formation.
In addition, it has been reported that overexpres-
sion of HSP27 at biopsy in patients with osteosarco-
ma is associated with a poor prognosis [49]. Inves-
tigations of HSPs, especially HSP27, in osteoblasts
suggest that HSP27 may contribute to physiological
and pathological processes such as osteosarcoma.
Further investigations concerned with HSP27 in os-
teoblasts are necessary to clarify the exact role of
HSP27 in bone metabolism.
It has been reported previously that the ligand-de-
pendent interaction between Smad 3 and retinoid X
receptor/vitamin D receptor heterocomplex is ob-
served and the cooperative actions of TGF-L and
vitamin D signaling pathways are mediated by
Smad 3 [27]. Thus, it is speculated that TGF-L and
various steroid hormones cooperatively regulate cell
function in some cell types. In the present study, ret-
inoic acid, which alone did not a¡ect the level of
HSP27, enhanced the TGF-L-induced HSP27 accu-
mulation in osteoblast-like MC3T3-E1 cells. In addi-
tion, we showed that retinoic acid, which by itself
had little e¡ect on the mRNA level for HSP27, am-
pli¢ed the TGF-L-induced increase in the mRNA for
HSP27. Therefore, our ¢ndings suggest that retinoic
acid acts as an enhancer in the TGF-L-induced
HSP27 in osteoblast-like MC3T3-E1 cells. We next
showed that PD98059 and SB203580 also inhibited
the retinoic acid enhancement of TGF-L-stimulated
HSP27 accumulation. Furthermore, retinoic acid
failed to a¡ect the phosphorylation of p44/p42
MAP kinase or p38 MAP kinase stimulated by
TGF-L. Therefore, it is probable that the e¡ect of
retinoic acid on the HSP27 induction stimulated by
TGF-L is exerted at a point downstream from p44/
p42 MAP kinase and p38 MAP kinase.
TGF-L is known to be an osteoinductive agent
while retinoic acid is recognized to act as a bone
resorptive agent. It has been reported that overex-
pression of TGF-L2 in osteoblasts causes an osteo-
porotic-like phenotype [50]. An increased osteoblas-
tic expression of TGF-L causes both an increase in
bone remodeling and an imbalance in osteoblastic
and osteoclastic activity leading to progressive bone
loss, a phenotype similar to high-turnover osteopo-
rosis. In the present study, we showed that TGF-L-
stimulated HSP27 induction was ampli¢ed by the
presence of retinoic acid, which alone did not a¡ect
HSP27 induction. These ¢ndings made us speculate
that the overexpression of the TGF-L-stimulated
HSP27 by retinoic acid in osteoblasts may upregulate
bone resorption. It is generally recognized that the
chaperoning function for most of the HSPs such as
HSP27 is their main function. In addition, intensive
deposition of extracellular matrix is observed during
bone remodeling. It has been reported that TGF-L
causes an increase in the steady state level of HSP47
mRNA in osteoblast-like MC3T3-E1 cells [22].
HSP47 is a procollagen/collagen-speci¢c molecular
chaperone protein. These ¢ndings make us speculate
that TGF-L-induced HSP27 assists the folding of
newly synthesized bone matrix proteins by TGF-L.
In addition, it is possible that retinoic acid might
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strengthen the TGF-L e¡ect via potentiation of
HSP27 induction.
In conclusion, these results strongly suggest that
TGF-L stimulates HSP27 induction through p44/
p42 MAP kinase activation and p38 MAP kinase
activation in osteoblasts, and that retinoic acid up-
regulates the TGF-L-stimulated HSP27 induction as
an ampli¢er at a point downstream from p44/p42
MAP kinase and p38 MAP kinase.
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